Gianluca is head of strategic planning and business development at Dompé, and sits on the board of Engitix Therapeutics. He previously held consulting roles at Tefen Management Consulting and T8P Consulting.
Marcello brings extensive scientific research experience within the pharmaceutical sector. He currently serves as Chief Scientific Officer at Dompé farmaceutici and sits on the scientific committee of Fondazione Dompé.
The financing round was co-led by Netherton Investments and Dompé farmaceutici.
"Our mission is to improve people’s lives and we partner with the best academic and industrial groups to accelerate the research that will bring new solutions to patients’ unmet needs. We look forward to working with the Engitix team to combine the power of Exscalate with Engitix’s deep understanding of the biology of the fibrosis and solid tumours microenvironment and the unique strength of its ECM platform. Our collaboration will enable us to accelerate the clinical translation of targets beyond our four key in-house therapeutic areas of ophthalmology, metabolic disorders, oncology, and pain management."
